Abbott Laboratories is buying Visiogen, a privately held ophthalmic device company based in California. The $400 million deal should close during the fourth quarter. Abbott, based in Illinois, bought Advanced Medical Optics earlier this year. Visiogen markets the Synchrony intraocular lens for presbyopia in cataract patients; it has been available in Europe since January and is undergoing testing by the U.S. government.